News and blog posts

28

May 2021

In April 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (repetitive short-pulse transscleral cyclophotocoagulation for glaucoma, deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults, and Melphalan chemosaturation for primary or metastatic cancer in the liver) and two Medtech Innovation Briefings (microINR for anticoagulation therapy and RenalSense Clarity RMS for acute kidney injury), and two clinical guidelines (for atrial fibrillation and chronic pain in over 16s). Read more

27

May 2021

In April 2021, the Austrian Institute for Health Technology Assessment (AIHTA) initiated several new research projects. The projects are related to IVD tests for early detection of colon cancer, telemedical care in diabetes field, health apps, screening methods, consequences of coronavirus pandemic, and other topics. Read more

26

May 2021

On May 6, 2021, the Federal Joint Committee (G-BA) announced the start of consultations about the design of three co-funded studies for cardiovascular methods in accordance with §137e SGB V. Read more

25

May 2021

On May 10, 2021, NICE announced the update of the evidence standards framework (ESF) for digital health technologies with changes in response to an ESF user survey that ran from October to December 2019. Furthermore, NICE launched a new Office for Digital Health to coordinate its digital health activities and strategic projects and manage collaboration with external partners. Read more

24

May 2021

The Galician Scientific and Technical Advice Unit in Spain (AVALIA-T) systematically evaluates healthcare technologies and provides decision-makers with critically reviewed information about their efficacy, safety, and effectiveness. Currently, the AVALIA-T is working on assessments of ventricular assist devices in pediatric patients with an indication for permanent destination therapy, bronchial thermoplasty for severe acute asthma, effectiveness and safety of epiduroscopy in the treatment of failed back surgery syndrome, and other topics. Read more

21

May 2021

In late April 2021, NHSX released a "2020-21: A year in the life of the NHS AI Lab" report representing NHS Artificial Intelligence Laboratory (AI Lab) achievements and work progress. Among other things, NHSX published results of the 2021 AI in Health and Care Survey, which shows that the diagnostic area remains the most popular for AI-based technologies compared to 2019. Read more

20

May 2021

Since 2022, the Dutch Healthcare Authority (NZa) implemented four new DRGs for surgical placement and removal of a heart rhythm monitor for reimbursement of the procedure performed by the cardiopulmonary surgeon. Read more

19

May 2021

The Innovation Committee at the Federal Joint Committee (G-BA) has launched the decisions database on its website. Read more

18

May 2021

On May 10, 2021, NHS Artificial Intelligence Laboratory (AI Lab) announced an open call to test AI-driven COVID-19 models using the National COVID-19 Chest Imaging Database (NCCID), collected over 40,000 X-rays, CT, and MRI images from people with and without coronavirus. The NHS AI Lab is now inviting research institutions and technology companies that develop AI-driven models using COVID-19 chest imaging data. The deadline for applications is May 28, 2021. Read more

17

May 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services Read more

17

May 2021

The Treatment Council (Behandlingsråd) is a new model for assessing treatment methods and health technologies, expected to become fully operational during 2021. On May 4, 2021, the first meeting of the Treatment Council was conducted. Also, the Treatment Council's Secretariat invites all the interested healthcare stakeholders to attend open online information meetings. Read more

14

May 2021

In late April 2021, the European Network for Health Technology Assessment, EUnetHTA, in partnership with the Austrian Institute for HTA (AIHTA), released a final report on the comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia. Twenty-one minimally invasive surgical treatments for benign prostatic hyperplasia were compared. Newer technologies may offer some advantage over transurethral resection of the prostate by reducing the transfusion requirement. Read more